An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis
Translational Gastroenterology and Hepatology · 2026-07 · 11 · 79-79
DOI: 10.21037/tgh-2026-0052 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-07. Verfasst von Elizabeth E Williams und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA.
ORCID-Profile: Elizabeth E Williams, Raj Vuppalanchi
Zitieren
APA
Williams, E. E., & Vuppalanchi, R. (2026). An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis. Translational Gastroenterology and Hepatology, 11, 79-79. https://doi.org/10.21037/tgh-2026-0052
Vancouver
Williams EE, Vuppalanchi R. An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis. Translational Gastroenterology and Hepatology. 2026;11:79-79. doi:10.21037/tgh-2026-0052
BibTeX
@article{Williams2026,
author = {Williams, Elizabeth E and Vuppalanchi, Raj},
title = {An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis},
journal = {Translational Gastroenterology and Hepatology},
year = {2026},
volume = {11},
pages = {79--79},
doi = {10.21037/tgh-2026-0052}
}
EUVIMED